Javascript must be enabled to continue!
Data Visualization Support for Tumor Boards and Clinical Oncology: Protocol for a Scoping Review (Preprint)
View through CrossRef
BACKGROUND
Complex and expanding data sets in clinical oncology applications require flexible and interactive visualization of patient data to provide the maximum amount of information to physicians and other medical practitioners. Interdisciplinary tumor conferences in particular profit from customized tools to integrate, link, and visualize relevant data from all professions involved.
OBJECTIVE
The scoping review proposed in this protocol aims to identify and present currently available data visualization tools for tumor boards and related areas. The objective of the review will be to provide not only an overview of digital tools currently used in tumor board settings, but also the data included, the respective visualization solutions, and their integration into hospital processes.
METHODS
The planned scoping review process is based on the Arksey and O’Malley scoping study framework. The following electronic databases will be searched for articles published in English: PubMed, Web of Knowledge, and SCOPUS. Eligible articles will first undergo a deduplication step, followed by the screening of titles and abstracts. Second, a full-text screening will be used to reach the final decision about article selection. At least 2 reviewers will independently screen titles, abstracts, and full-text reports. Conflicting inclusion decisions will be resolved by a third reviewer. The remaining literature will be analyzed using a data extraction template proposed in this protocol. The template includes a variety of meta information as well as specific questions aiming to answer the research question: “What are the key features of data visualization solutions used in molecular and organ tumor boards, and how are these elements integrated and used within the clinical setting?” The findings will be compiled, charted, and presented as specified in the scoping study framework. Data for included tools may be supplemented with additional manual literature searches. The entire review process will be documented in alignment with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) flowchart.
RESULTS
The results of this scoping review will be reported per the expanded PRISMA-ScR guidelines. A preliminary search using PubMed, Web of Knowledge, and Scopus resulted in 1320 articles after deduplication that will be included in the further review process. We expect the results to be published during the second quarter of 2024.
CONCLUSIONS
Visualization is a key process in leveraging a data set’s potentially available information and enabling its use in an interdisciplinary setting. The scoping review described in this protocol aims to present the status quo of visualization solutions for tumor board and clinical oncology applications and their integration into hospital processes.
CLINICALTRIAL
INTERNATIONAL REGISTERED REPORT
DERR1-10.2196/53627
JMIR Publications Inc.
Title: Data Visualization Support for Tumor Boards and Clinical Oncology: Protocol for a Scoping Review (Preprint)
Description:
BACKGROUND
Complex and expanding data sets in clinical oncology applications require flexible and interactive visualization of patient data to provide the maximum amount of information to physicians and other medical practitioners.
Interdisciplinary tumor conferences in particular profit from customized tools to integrate, link, and visualize relevant data from all professions involved.
OBJECTIVE
The scoping review proposed in this protocol aims to identify and present currently available data visualization tools for tumor boards and related areas.
The objective of the review will be to provide not only an overview of digital tools currently used in tumor board settings, but also the data included, the respective visualization solutions, and their integration into hospital processes.
METHODS
The planned scoping review process is based on the Arksey and O’Malley scoping study framework.
The following electronic databases will be searched for articles published in English: PubMed, Web of Knowledge, and SCOPUS.
Eligible articles will first undergo a deduplication step, followed by the screening of titles and abstracts.
Second, a full-text screening will be used to reach the final decision about article selection.
At least 2 reviewers will independently screen titles, abstracts, and full-text reports.
Conflicting inclusion decisions will be resolved by a third reviewer.
The remaining literature will be analyzed using a data extraction template proposed in this protocol.
The template includes a variety of meta information as well as specific questions aiming to answer the research question: “What are the key features of data visualization solutions used in molecular and organ tumor boards, and how are these elements integrated and used within the clinical setting?” The findings will be compiled, charted, and presented as specified in the scoping study framework.
Data for included tools may be supplemented with additional manual literature searches.
The entire review process will be documented in alignment with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) flowchart.
RESULTS
The results of this scoping review will be reported per the expanded PRISMA-ScR guidelines.
A preliminary search using PubMed, Web of Knowledge, and Scopus resulted in 1320 articles after deduplication that will be included in the further review process.
We expect the results to be published during the second quarter of 2024.
CONCLUSIONS
Visualization is a key process in leveraging a data set’s potentially available information and enabling its use in an interdisciplinary setting.
The scoping review described in this protocol aims to present the status quo of visualization solutions for tumor board and clinical oncology applications and their integration into hospital processes.
CLINICALTRIAL
INTERNATIONAL REGISTERED REPORT
DERR1-10.
2196/53627.
Related Results
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Giant Sacrococcygeal Teratoma in Infant: Systematic Review
Abstract
Introduction
Sacrococcygeal teratoma (SCT) is a rare embryonal tumor that occurs in the sacrococcygeal region, with an incidence of about 1 in 35,000 to 40,000 live births...
A Survey on Beagle Boards and its Applications
A Survey on Beagle Boards and its Applications
<p>This paper consists of an overview and a brief description of all the Beagle Boards from the original Beagle Board released in 2008 to the latest board BeagleV released in...
Well-being focused interventions for caregivers of children with developmental disabilities-a scoping review protocol
Well-being focused interventions for caregivers of children with developmental disabilities-a scoping review protocol
AbstractIntroductionChildren with developmental disabilities (DD) have complex health needs which imply that they will need assistance in many areas of their lives, a role usually ...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Carcinoma ex Pleomorphic Adenoma: A Case Series and Literature Review
Abstract
Introduction
Carcinoma ex pleomorphic adenoma (CXPA) is a rare malignant salivary gland tumor that can lead to severe complications and carries a risk of distant metastasi...

